Could a 2-Week check catch postpartum depression sooner?

NCT ID NCT07460063

First seen Mar 20, 2026 · Last updated Jun 23, 2026 · Updated 15 times

Summary

This study will test if screening new mothers for postpartum depression at 2-3 weeks after birth, instead of the usual 6-8 weeks, helps identify signs earlier. Researchers will randomly assign 428 women who delivered at Massachusetts General Hospital to either early or routine screening. Participants will fill out a short depression questionnaire online, and their doctors will decide on any follow-up care. The study will follow each woman for 6 months to see if earlier screening makes a difference.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION (PPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Edinburgh Perinatal Depression Scale (EPDS) questionnaire

What this could lead to

If earlier screening proves effective, it could lead to earlier support and treatment for new mothers with postpartum depression.

What could go wrong

This is a small, early-stage study that only looks at screening timing, not treatment. Results may not apply to all women or settings.

Conditions

The condition(s) this trial relates to.

Depression postpartum depression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.